Dipayan Bose

Dipayan Bose

Auto-generated profile, based on publicly available information

Dipayan Bose

Departments of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine at the University of Pennsylvania

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SBSagarika Banerjee
Sagarika Banerjee
ZWZhi Wei
Zhi Wei
TTTian Tian
Tian Tian
DBDipayan Bose
Dipayan Bose
NSNatalie N. C. Shih
Natalie N. C. Shih
Erle S RobertsonErle S Robertson
Erle S Robertson
Alterations to the natural microbiome are linked to different diseases, and the presence or absence of specific microbes is directly related to disease outcomes. We performed a comprehensive analysis with unique cohorts of the four subtypes of breast cancer (BC) characterized by their microbial signatures, using a pan-pathogen microarray strategy. The signature (includes viruses, bacteria, fungi, and parasites) of each tumor subtype was correlated with clinical data to identify microbes with prognostic potential. The subtypes of BC had specific viromes and microbiomes, with ER+ and TN tumors showing the most and least diverse microbiome, respectively. The specific microbial signatures allowed discrimination between different BC subtypes. Furthermore, we demonstrated correlations between the presence and absence of specific microbes in BC subtypes with the clinical outcomes. This study provides a comprehensive map of the oncobiome of BC subtypes, with insights into disease prognosis that can be critical for precision therapeutic intervention strategies.

27 March 2015 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
YSYEASIN SIKDAR
YEASIN SIKDAR
RMRitwik Modak
Ritwik Modak
DBDipayan Bose
Dipayan Bose
SBSaswati Banerjee
Saswati Banerjee
DBDariusz Bieńko
Dariusz Bieńko
SGSanchita Goswami
Sanchita Goswami
We have synthesized and structurally characterized a new doubly chloro bridged dimeric copper(II) complex, [Cu2(μ-Cl)2(HL)2Cl2] (1) based on a Schiff base ligand, 5-[(pyridin-2-ylmethylene)-amino]-pentan-1-ol). Single crystal X-ray diffraction shows the presence of dinuclear copper(II) centres in a square pyramidal geometry linked by obtuse double chloro bridge. The magnetic study illustrated that weak antiferromagnetic interactions (J = −0.47 cm−1) prevail in complex 1 which is well supported by magneto-structural correlation. This compound adds to the library of doubly chloro bridged copper(II) complexes in the regime of spin state cross over. DFT calculations have been conducted within a broken-symmetry (BS) framework to investigate the exchange interaction further which depicts that the approximate spin projection technique yields the best corroboration of the experimental J value. Spin density plots show the presence of an ∼0.52e charge residing on the copper atom along with a substantial charge on bridging and peripheral chlorine atoms. The potential of complex 1 to act as an anticancer agent is thoroughly examined on a series of liver cancer cell lines and screening shows the HepG2 cell line exhibits maximum cytotoxicity by phosphatidyl serine exposure in the outer cell membrane associated with ROS generation and mitochondrial depolarization with increasing time in the in vitro model system.

6 January 2012 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SASirsendu Das Adhikary
Sirsendu Das Adhikary
DBDipayan Bose
Dipayan Bose
PMPartha Mitra
Partha Mitra
KSKrishna Das Saha
Krishna Das Saha
VBValerio Bertolasi
Valerio Bertolasi
JDJoydev Dinda
Joydev Dinda
Novel Au(I)-N-heterocyclic carbene complexes, 1-methyl-3-(2-pyridylmethyl)-benzimidazolylidenegold(I)-chloride, 1; 1-benzyl-3-(2-pyridylmethyl)-benzimidazolylidenegold(I)chloride, 2; and Pt(II)-N-heterocyclic carbene complexes 1-methyl-3-(2-pyridylmethyl) benzimidazolylidene platinum(II)chloride, 3; and 1-benzyl-3-(2-pyridylmethyl) benzimidazolylidene platinum-(II)chloride, 4, have been synthesized, based on CN-donor proligands 1-alkyl-3-(2-pyridylmeth-yl)-benzimidazoliumchloride L1 and L2 [alkyl, R = –CH3 = L1; R = –CH2Ph = L2]. All the compounds have been synthesized and characterized by different spectroscopic methods. The Au(I) complexes 1 and 2 have been synthesized by a silver carbene transfer method. The solid-state structures of 1 and 3 have been determined by single crystal X-ray diffraction studies. The square planar Pt(II) complexes 3 and 4 show a reversible Pt(II)/Pt(IV) couple at 0.69 eV and 0.67 eV respectively. Among the complexes 1–4, complexes 1 and 3 have been used for cytotoxicity studies on the cell lines B16F10 (mouse melanoma), HepG2 (human hepatocarcinoma) and HeLa (human cervical carcinoma). IC50 values are compared with cisplatin, among 1 and 3, the Au(I) complex 1 is more effective than Pt(II) complex 3.

5 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SDSumit Kumar Dey
Sumit Kumar Dey
DBDipayan Bose
Dipayan Bose
AHAbhijit Hazra
Abhijit Hazra
SNSubhendu Naskar
Subhendu Naskar
ANAbhishek Nandy
Abhishek Nandy
KSKrishna Das Saha
Krishna Das Saha
Anticancer role of andrographolide is well documented. To find novel potent derivatives with improved cytotoxicity than andrographolide on cancer cells, two series of di-spiropyrrolidino- and di-spiropyrrolizidino oxindole andrographolide derivatives prepared by cyclo-addition of azomethine ylide along with sarcosine or proline (viz. sarcosine and proline series respectively) and substitution of different functional groups (-CH3, -OCH3 and halogens) were examined for their cytotoxic effect on a panel of six human cancer cell lines (colorectal carcinoma HCT116 cells, pancreatic carcinoma MiaPaCa-2 cells, hepatocarcinoma HepG2 cells, cervical carcinoma HeLa cells, lung carcinoma A549 and melanoma A375 cells). Except halogen substituted derivatives of proline series (viz. CY2, CY14 and CY15 for Br, Cl and I substitution respectively), none of the other derivatives showed improved cytotoxicity than andrographolide in the cancer cell lines examined. Order of cytotoxicity of the potent compounds is CY2>CY14>CY15>andrographolide. Higher toxicity was observed in HCT116, MiaPaCa-2 and HepG2 cells. CY2, induced death of HCT116 (GI50 10.5), MiaPaCa-2 (GI50 11.2) and HepG2 (GI50 16.6) cells were associated with cell rounding, nuclear fragmentation and increased percentage of apoptotic cells, cell cycle arrest at G1 phase, ROS generation, and involvement of mitochondrial pathway. Upregulation of Bax, Bad, p53, caspases-3,-9 and cleaved PARP; downregulation of Bcl-2, cytosolic NF-κB p65, PI3K and p-Akt; translocation of P53/P21, NF-κB p65 were seen in CY2 treated HCT116 cells. Thus, three halogenated di-spiropyrrolizidino oxindole derivatives of andrographolide are found to be more cytotoxic than andrographolide in some cancer cells. The most potent derivative, CY2 induced death of the cancer cells involves ROS dependent mitochondrial pathway like andrographolide.

1 August 2019 in Toxicology in Vitro
Verified
Journal Article
Closed access
DBDipayan Bose
Dipayan Bose
SBSomenath Banerjee
Somenath Banerjee
NCNabanita Chatterjee
Nabanita Chatterjee
SDSubhadip Das
Subhadip Das
MSMoumita Saha
Moumita Saha
KSKrishna Das Saha
Krishna Das Saha

19 July 2021 in eLife
Verified
Journal Article
Open access
RSRajnish Singh
Rajnish Singh
YPYonggang Pei
Yonggang Pei
DBDipayan Bose
Dipayan Bose
ZLZachary L Lamplugh
Zachary L Lamplugh
KSKunfeng Sun
Kunfeng Sun
Erle S RobertsonErle S Robertson
Erle S Robertson
The cellular adaptive response to hypoxia, mediated by high HIF1α levels includes metabolic reprogramming, restricted DNA replication and cell division. In contrast to healthy cells, the genome of cancer cells, and Kaposi’s sarcoma associated herpesvirus (KSHV) infected cells maintains replication in hypoxia. We show that KSHV infection, despite promoting expression of HIF1α in normoxia, can also restrict transcriptional activity, and promoted its degradation in hypoxia. KSHV-encoded vCyclin, expressed in hypoxia, mediated HIF1α cytosolic translocation, and its degradation through a non-canonical lysosomal pathway. Attenuation of HIF1α levels by vCyclin allowed cells to bypass the block to DNA replication and cell proliferation in hypoxia. These results demonstrated that KSHV utilizes a unique strategy to balance HIF1α levels to overcome replication arrest and induction of the oncogenic phenotype, which are dependent on the levels of oxygen in the microenvironment.